Robert A. Panora - 27 May 2025 Form 4/A - Amendment Insider Report for TECOGEN INC. (TGEN)

Reporting relationship: COO and President
Issuer ticker: TGEN
Reported as of: 27 May 2025
Net transaction value: $0
SEC form: 4/A - Amendment
Accepted by SEC: 14 Jul 2025, 09:00:45 UTC
Original report date: 02 Jun 2025
Prior SEC filing: 06 May 2022
Next SEC filing: 14 Jul 2025
Source filing: View source filing
Reporting owner signature: /s/ Robert A. Panora

Key filing fact

Robert A. Panora filed Form 4/A - Amendment for TECOGEN INC. (TGEN) on 14 Jul 2025.

Key facts

This page summarizes Robert A. Panora's Form 4/A - Amendment filing for TECOGEN INC. (TGEN).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 14 Jul 2025, 09:00.

Change

Previous filing in this sequence was filed on 06 May 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reporting Owners (1)

CIK 0001585814 Primary reporting owner

PANORA ROBERT A

Relationship: COO and President
Address: C/O TECOGEN, INC., 76 TREBLE COVE ROAD, BLDG 1, N. BILLERICA
Signature: /s/ Robert A. Panora
Signature date: 14 Jul 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TGEN transaction

Common Stock

Options Exercise

Transaction value: $49,700
Shares: +70,000
Change %
Price: $0.7100
Shares after: 70,000
Date: 27 May 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TGEN transaction Derivative

Stock Options (Right to Buy)

Options Exercise

Transaction value: $49,700
Shares: -70,000
Change %: -35%
Price: $0.7100
Shares after: 130,000
Date: 27 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 70,000
Exercise price: $0.7100
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Transaction code corrected

Footnote F2

100,000 shares of the 200,000 option shares granted pursuant to Stock Option Agreement dated 7/9/2020 vested on 6/30/2022 upon achievement of Adjusted EBITDA performance milestone.